Gepato-gastroenterologik tadqiqotlar jurnali 2026 №1

Maqola mavzusi

GLOMERULONEFRITGA ChALINGAN BEMORLARNI DAVOLASHDA QO’LLANILADIGAN GLYUKOKORTIKOIDLARNING OSHQOZON-ICHAK TIZIMIGA NOJO‘YA TA’SIRLARI VA ULARNING OLDINI OLISH (15-19)

Mualliflar

Ахmatov Ablokul Axmatovich

Muassasa

Samarqand davlat tibbiyot universiteti

Annotatsiya

Mazkur maqolada glomerulonefritga chalingan bemorlarni davolashda qo‘llaniladigan glyukokortikosteroidlarning oshqozon-ichak tizimiga ko‘rsatadigan nojo‘ya ta’sirlari kompleks tarzda o’rganildi va tahlil qilindi. Tadqiqotda 5-18 yoshdagi 120 nafar nefrotik sindromga chalingan bemorlarni glyukokortikosteroidlar bilan davolash fonida rivojlanadigan gastrit, yara va gastrointestinal qon ketish holatlari o‘rganildi. Olingan natijalar gastroprotektiv vositalar qo‘llanilganda asoratlar sezilarli darajada kamayishini ko‘rsatdi.

Kalit so'zlar

Kalit so‘zlar: glomerulonefrit, glyukokortikosteroidlar, gastrit, yara, gastroproteksiya.

Adabiyotlar

Список литературы/ Iqtiboslar / References 1. American Journal of Nephrology. Clinical studies on glomerulonephritis. – 2023. 2. Basic & Clinical Pharmacology / B.G. Katzung. – New York: Mc Graw-Hill, 2021. 3. Brenner B.M., Rector F.C. The Kidney. – Philadelphia: Elsevier, 2020. 4. 20. Brenner B.M., Rector F.C. The Kidney.- Philadelphia: Elsevier,2020. 5. George C., Mogueo A., Okpechi I., Echouffo-Tcheugui J.B., Kengne A.P. Chronic kidney disease in low-income to middle-income countries: the case for increased screening. BMJ. Glob. Health. 2017; 2(2): Р.256. 6. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. – Mc Craw-Hill, 2022. 7. Go D.S., Kim S.H., Park J., Ryu D.R., Lee H.J., Jo M.W. Cost-utility analysis of the National Health Screening Program for chronic kidney disease in Korea. Nephrology (Carlton). 2019; 24(1): 56–64. 8. Harrison’s Principles of Internal Medicine. – New York: McGraw-Hill, 2022. 9. Daminova M.A. Chronic kidney disease in children: etiology, classification and progression factors // Bulletin of modern clinical medicine. - 2016. - V. 9 (2). - P. 36-41. 10. Davydov V.V., Arekhina E.L. The role of cystatin C in early diagnosis of chronic kidney disease progression in patients with acute decompensation of chronic heart failure//Consiliummеdicum. 2018. - No. 12. - P. 30-34. 11. Dildabekova A.S. Cystatin C in the diagnosis of acute and chronic kidney injury // International Journal of Applied and Fundamental Research. 2016. No. 11-1. P. 66-70. 12. Dildabekova A.S., Abeuova B.A., Begaidarova R.Kh. Cystatin C in the diagnosis of glomerular filtration dysfunction in children with acute intestinal infections // Issues of Practical Pediatrics. - 2017. - No. 1. - P. 41-43 . 14. KDIGO Clinical Practice Guideline for Glomerulonephritis. – Kidney International Supplements, 2021. 15. Koppe L., Fouque D. The Role for Protein Restriction in Addition to Renin Angiotensin-Aldosterone System Inhibitors in the Management of CKD. Am. J. Kidney Dis. 2019;73(2):248–257. 16. Lancet Gastroenterology & Hepatology. – 2022. 17. Munter P., He J, Hamm L. et al. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States Nephrol-2012, 13,745-753. 18. Sleisenger M.H., Feldman M. Gastrointestinal and Liver Disease. – 2021. 19. Saran R., Robinson B., Abbott K.C., Agodoa L.Y.C., Bragg-Gresham J., Balkrishnan R., Bhave N., Dietrich X., Ding Z., Eggers P.W., Gaipov A., Gillen D., Gipson D., Gu H., et al. US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am. J. Kidney Dis. 2019; 73(3S1):A7–A8. 20. Smirnova N.N.Modern biomarkers of kidney injury in pediatrics // Nephrology. - 23(4).-2019.-С. 112-118. 21. Tantisattamo E., Dafoe D.C., Reddy U.G., Ichii H., Rhee C.M., Streja E., Landman J., Kalantar-Zadeh K. Current Management of Acquired Solitary Kidney. Kidney International Reports. 2019; 4(9):1205–1218.